Source map — High cost of GLP-1s drives some to seek cheaper, unregulated versions
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| PBS | news | 60% |
| Fierce Pharma | news | 60% |
| AOL.com | news | 60% |
| Bioengineer.org | news | 60% |
| Pharmaceutical Executive | news | 60% |